J+J seeks permission for phase-3 trial of its single-shot COVID vaccine in India, import licence - Android

New Delhi, Apr 19: Multinational pharma giant Johnson & Johnson has applied to India''s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, sources said. They said the company has